James Butrynski, MD
Hematology & Oncology · Eugene, ORNPI 1427134287
Payments from drug & device makers
Across 416 payments — averaging $1760.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mirati Therapeutics, Inc.$421K
- AstraZeneca$102K
- Genentech, Inc.$82K
- Janssen Research & Development, LLC$30K
- Eli Lilly$28K
- Amgen$15K
- plus $55K from 10 others
Across 38 payments — averaging $563.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Scientific Affairs, LLC$21K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mirati Therapeutics, Inc. | 150 | $420,568 |
| AstraZeneca | 8 | $101,950 |
| Genentech, Inc. | 17 | $81,502 |
| Janssen Research & Development, LLC | 79 | $30,265 |
| Eli Lilly | 4 | $27,860 |
| Amgen | 5 | $15,437 |
| Merck | 5 | $13,414 |
| Bayer | 5 | $12,550 |
| Gilead | 4 | $12,012 |
| Janssen Scientific Affairs, LLC | 132 | $9,534 |
| Lilly USA, LLC | 1 | $6,180 |
| Boehringer Ingelheim | 2 | $723 |
| Aadi Bioscience, Inc. | 1 | $105 |
| Astellas Pharma US Inc | 1 | $100 |
| Biocompatibles, Inc. | 1 | $94 |
| E.r. Squibb & Sons, L.L.C. | 1 | $12 |
How this compares
$732,306 in reported general payments places this provider in the 80th percentile of 112 hematology & oncology providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other hematology & oncology in Eugene
- Christopher YasenchakEugene$2.4M
- Luke FletcherEugene$2M
- Miho DoughertyEugene$819K
- Matthew LonerganEugene$202K
- Jae LeeEugene$10K
- Michael HeinrichPortland$25M
- Jay AndersenPortland$8.3M
- Elie TraerPortland$6.5M
- Ian SchnadigTualatin$6.4M
- Jacqueline VukyPortland$5.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.